Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KB003 in Inadequately Controlled Asthma
NCT01603277Phase 2Completed
- Sponsor
- Humanigen
- Start
- Jul 2012
- Primary completion
- Jul 2013
- Modality
- Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 2 trial of lenzilumab in asthma, sponsored by Humanigen. Started Jul 2012; status: completed.
02
Drugs
lenzilumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01603277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01603277.